Timothy Gayowski

Author PubWeight™ 13.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med 2005 1.75
2 Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation 2004 1.43
3 Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004 1.22
4 Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrob Agents Chemother 2002 1.09
5 Cryptococcus neoformans Infection in Patients With Cirrhosis, Including Liver Transplant Candidates. Medicine (Baltimore) 2004 1.04
6 Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates. Transplantation 2003 1.01
7 Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant 2002 0.91
8 Bleeding complications precipitated by unrecognized Gingko biloba use after liver transplantation. Transpl Int 2002 0.87
9 Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease. Transplantation 2005 0.86
10 Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices. Transplantation 2002 0.82
11 Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years. Transplantation 2005 0.81
12 Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis. Transplantation 2002 0.80
13 Impact of evolving trends in recipient and donor characteristics on cytomegalovirus infection in liver transplant recipients. Transplantation 2004 0.77
14 Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients. J Clin Pharmacol 2002 0.75
15 A real-time, telemetric method for continuous measurement of portal pressures. J Surg Res 2009 0.75